|
|
|
| home > white papers > Overcoming research challenges with Adaptive Trials - PCI Pharma Services |
|
|
 WHITE PAPERS |
|
PCI Pharma Services
|
|
Overcoming research challenges with Adaptive Trials
|
|
There has been cause for concern within the pharmaceutical industry over
the last five years, regarding increasing research and development
costs, combined with a fall in the number of new drugs brought to
market. In an attempt to overcome this issue there has been a
significant rise in the use of adaptive clinical trial designs, whilst
saving time and money as well as facilitating more effective decision
making. One of the biggest challenges that pharmaceutical companies have
experienced has been delivering compliant clinical trials supplies
across diverse patient populations in the relatively short timeframes
that adaptive trial designs require, remaining focused on ensuring that
patient compliance and product quality is in no way compromised. This
demand has led to the launch of fast response services that support
Research and Development in responding to changing dosing regimens
mid-trial.
|
|
|
|
|
|
|
 |
News and Press Releases |
 |
Ariceum Therapeutics Appoints Chief Business Officer
BERLIN, 7 July 2022 – Ariceum Therapeutics (Ariceum), a private
biotech company developing radiopharmaceutical products for the
diagnosis and systemic targeted radiation therapy of certain
hard-to-treat cancers, is pleased to announce the appointment of Serge
Sagodira as Chief Business Officer. Appointed from 1 July 2022, Serge
will oversee all business development aspects of the company, leveraging
his considerable expertise in licensing and transactions over a 20-year
career in business development within the Life Sciences sector. He will
work closely with the Ariceum leadership team to establish long-term
strategic and value-creating collaborations with industry leaders as
well as renowned academic groups in the field of radiopharmaceuticals.
More info >> |
|
 |
White Papers |
 |
|
Clinical Trial-Specific Travel Programs as a Patient Retention Tool
For many patients, participating in a clinical trial is a major endeavor. Depending on the protocol requirements, study visits can be exhausting. There are a number of reasons why a patient may choose to participate in a trial only to drop out. Conversely, there are several approaches to proactively try to prevent this from happening. There are various methods professionals implement for patient retention. This white paper explores patient travel services as one patient retention strategy.
More info >> |
|
|
|
